ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Clinical Diabetes

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1505143

The Rising Burden of Diabetes and Statewise Variations in India: Insights and projections to 2031 from the Global Burden of Disease Study 1990-2021

Provisionally accepted
Shubham  ChauhanShubham Chauhan1Mahalaqua  Nazli KhatibMahalaqua Nazli Khatib2Suhas  BallalSuhas Ballal3Pooja  BansalPooja Bansal4Kiran  BhopteKiran Bhopte5Abhay  M GaidhaneAbhay M Gaidhane2Balvir  S TomarBalvir S Tomar6Ayash  AshrafAyash Ashraf7M  Ravi KumarM Ravi Kumar8Ashish  Singh ChauhanAshish Singh Chauhan9Muhammed  ShabilMuhammed Shabil10Diptismita  JenaDiptismita Jena11Ganesh  BushiGanesh Bushi12Shailesh  Kumar SamalShailesh Kumar Samal13*Lara  JainLara Jain11Vaibhav  JaiswalVaibhav Jaiswal5Manvi  PantManvi Pant14
  • 1Global Center for Evidence Synthesis (GCES), Chandigarh, Haryana, India
  • 2Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India
  • 3Jain University, Bengaluru, Karnataka, India
  • 4Vivekananda Global University, Jaipur, Rajasthan, India
  • 5IES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India
  • 6NIMS University, Jaipur, Rajasthan, India
  • 7Chandigarh Group of Colleges, Mohali, Punjab, India
  • 8Raghu Engineering College, Visakhapatnam, Andhra Pradesh, India
  • 9Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India
  • 10Chandigarh University, Mohali, Punjab, India
  • 11Graphic Era University, Dehradun, Uttarakhand, India
  • 12Lovely Professional University, Phagwara, Punjab, India
  • 13Karolinska Institutet (KI), Solna, Sweden
  • 14New Delhi Institute of Management, New Delhi, India

The final, formatted version of the article will be published soon.

Background: Diabetes is a major public health concern in India, contributing significantly to morbidity and mortality. With variations in disease burden across states, a detailed understanding of trends in incidence, prevalence, and Disability Adjusted Life Years (DALYs) is essential for targeted interventions.Methods: This study utilized Global Burden of Disease (GBD) data from 1990 to 2021 to examine trends in diabetes across Indian states. Age-standardized incidence, prevalence, mortality, and DALYs were analyzed using Join point regression to estimate Annual Percentage Change (APC). Autoregressive Integrated Moving Average (ARIMA) models were employed to project diabetes trends up to 2031.While the GBD data provide robust national and regional estimates, their modeled nature may not capture the full spectrum of local epidemiological variations.Results: Diabetes incidence increased from 162.74 to 264.53 per 100,000 between 1990 and 2021, with an APC of 0.63%. Joinpoint analysis identified episodic surges in incidence, with APCs of 2.25% during 1996-1999 and 2.07% during 2005-2011, suggesting intervals of accelerated increase relative to the gradual progression typically observed in chronic conditions. Mortality rose from 23.09 to 31.12 per 100,000 (APC: 0.12%). Southern and Western states, such as Tamil Nadu and Goa, exhibited the highest prevalence and DALYs. Forecasted trends indicate that by 2031, the prevalence will reach 8585.45 per 100,000, and DALYs will exceed 1241.57 per 100,000. States like Bihar and Jharkhand showed moderate changes, while Goa had the highest rise in prevalence.The burden of diabetes in India has significantly increased, particularly in Southern and Western regions.risen markedly over the past three decades. These findings highlightunderscore the urgent need for region-specific health policies focused onthat emphasize lifestyle modifications and enhancedimproved healthcare access. Tailored interventions targeting high-burden states are crucialA comprehensive approach that integrates primary prevention through community-based health education, dietary counseling, and initiatives to promote physical activity with secondary prevention measures such as systematic screening and timely clinical management, is essential for effective diabetes control and management in high-burden states.

Keywords: Font: (Default) Times New Roman Font: (Default) Times New Roman Font: (Default) Times New Roman Font: (Default) Times New Roman Font: (Default) Times New Roman Font: (Default) Times New Roman Diabetes, Incidence, Mortality, DALYs, India, GBD study, ARIMA, Regional Disparities English (United States)

Received: 03 Oct 2024; Accepted: 09 Apr 2025.

Copyright: © 2025 Chauhan, Khatib, Ballal, Bansal, Bhopte, Gaidhane, Tomar, Ashraf, Kumar, Chauhan, Shabil, Jena, Bushi, Samal, Jain, Jaiswal and Pant. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Shailesh Kumar Samal, Karolinska Institutet (KI), Solna, Sweden

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.